Medium materiality6/10
Zenas BioPharma price target raised to $32 from $22 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target above the current price, implying upside potential.
- Target $32 vs posted price $29.84.
Key facts
- 01
Target: $32
- 02
Posted price: $29.84
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.